Cargando…
When and how to use predictive biomarkers for corticosteroid treatment of septic shock
Autor principal: | Russell, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249723/ https://www.ncbi.nlm.nih.gov/pubmed/30463607 http://dx.doi.org/10.1186/s13054-018-2254-z |
Ejemplares similares
-
Potential for overuse of corticosteroids and vasopressin in septic shock
por: Hsu, Joe L, et al.
Publicado: (2012) -
Vasopressors in septic shock: which, when, and how much?
por: Shi, Rui, et al.
Publicado: (2020) -
How much fluid resuscitation is optimal in septic shock?
por: Russell, James A
Publicado: (2012) -
Timing of vasoactive agents and corticosteroid initiation in septic shock
por: Ammar, Mahmoud A., et al.
Publicado: (2022) -
Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock
por: Thompson, Kelly, et al.
Publicado: (2021)